How to administer the investigational radiopharmaceutical 177Lu-PSMA-I&T Science Animated 3:30 1 year ago 3 700 Скачать Далее
ECLIPSE - A Randomized Phase 3 Trial for 177-Lu-PSMA-I&T in patients with mCRPC Science Animated 2:24 1 year ago 3 820 Скачать Далее
Upfront [177Lu]Lu-PSMA-617 radioligand therapy prior to radical prostatectomy in men with HR PC ecancer 4:28 1 year ago 364 Скачать Далее
177Lu-PSMA-617 for prostate cancer: TheraP, VISION, UpFrontPSMA and LuTectomy VJOncology 6:45 3 years ago 1 748 Скачать Далее
Dr. Strosberg on Future of 177Lu-Dotatate Therapy in Neuroendocrine Tumors OncLive 1:19 7 years ago 1 245 Скачать Далее
177Lu-PSMA-617 for the early treatment of prostate cancer VJOncology 5:37 3 years ago 1 620 Скачать Далее
VISION: tolerability of 177Lu-PSMA-617 by treatment exposure in patients with mCRPC VJOncology 3:03 2 years ago 730 Скачать Далее
NETTER-1 update: 177Lu-DOTATATE in patients with midgut neuroendocrine tumors VJOncology 1:59 3 years ago 410 Скачать Далее
177Lu-DOTATATE in patients with well-differentiated, high-grade NETs VJOncology 1:57 1 year ago 111 Скачать Далее
The benefits of 177Lu-PSMA-617 plus olaparib for prostate cancer VJOncology 1:06 1 year ago 209 Скачать Далее
Dr. Strosberg on Retreatment With 177Lu-Dotatate in Advanced NETs OncLive 1:03 3 years ago 325 Скачать Далее
Production of n.c.a. Lutetium-177 / EndolucinBeta® for Targeted Radionuclide Therapy ITM Isotope Technologies Munich SE 2:46 6 years ago 6 810 Скачать Далее
Fractionated dose 177Lu-PSMA-617 in patients with mCRPC VJOncology 5:30 2 years ago 264 Скачать Далее
Predicting 177Lu-PSMA-617 in men with prostate cancer with nomograms VJOncology 0:54 2 years ago 244 Скачать Далее
